To conclude, our study reveals an important role for cardiomyocyte specific deletion of TLR4 in protection from Ang II-induced hypertension by reducing cardiac hypertrophy, fibrosis, and blunting inflammation. This evidence concerns the gene TLR4 and cardiac hypertrophy.